Brief: Adaptive Biotechnologies Q3 EPS USD 0.06
05/11/2025 21:06
Nov 05 (Reuters) - Adaptive Biotechnologies Q3 revenue USD 93.973 million vs. IBES estimate USD 58.9 million. Q3 operating expenses USD 83.683 million Q3 net income USD 9.545 million Q3 operating income USD 10.29 million Q3 adjusted EBITDA USD 28 million vs. IBES estimate USD -10.4 million
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile